Clinical trial · Interventional
Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)
Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis
NCT04221464CI-TRIAL-00085842BCBrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Peritoneal Carcinosis | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biological collection | Biological | — | UNRESOLVED |
| Tissues collections | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Tumors and blood collection
- description
- For all the patients include in the study : * Blood samples will be collected at different times : before any treatment, at every surgery, one month after any surgery, at progression. * Tumours and not tumours tissues will be collected at different times : Before any surgery, one month after any surgery In parallel to this biological collection, standardized clinical data will be entered into a database treatment, at every surgery
- interventionNames
- Biological: biological collection
- Other: Tissues collections
Primary outcomes (1)
- measure
- Proportion of patients who gave their consent to participate in the study
- timeFrame
- Until the study completion: 4 years
- description
- The proportion of patients who consent to participate in the study among the screened patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient over the age of 18; * Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer * Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease * Patient agree will all study procedure : biological samples \& tissues samples * Patient giving informed consent Exclusion Criteria: * Patient not affiliated to Social Protection system * Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons * The level of French is insufficient to consent to the study and to response to the questionnaires * Patient under guardianship * Pregnancy ou breast-feeding women * Patient treated in case of an emergency
References
Publications (0)
Data not yet available
No reference posted for this study.